European Journal of Medicinal Chemistry p. 29 - 43 (2018)
Update date:2022-08-02
Topics:
OuYang, Yiqiang
Zou, Wensheng
Peng, Liang
Yang, Zunhua
Tang, Qidong
Chen, Mengzi
Jia, Shuang
Zhang, Hong
Lan, Zhou
Zheng, Pengwu
Zhu, Wufu
Eight series of quinazoline derivatives bearing 2,3-dihydro-indole or 1,2,3,4-tetrahydroquinoline were designed, synthesized and evaluated for the IC50 values against three cancer cell lines (A549, MCF-7 and PC-3). Most of the forty nine target compounds showed excellent antiproliferative activity against one or several cancer cell lines. The compound 13a showed the best activity against A549, MCF-7 and PC-3 cancer cell lines, with the IC50 values of 1.09 ± 0.04 μM, 1.34 ± 0.13 μM and 1.23 ± 0.09 μM, respectively. Eight selected compounds were further selected to evaluated for the inhibitory activity against EGFR kinase. Three of them showed equal activity against EGFR kinase to positive control afatinib. AnnexinV-FITC, propidium iodide (PI) double staining and acridine orange single staining results indicated that the compound 13a could induce apoptosis of human lung cancer A549 cells.
View MoreChemieliva Pharmaceutical Co., Ltd.
website:http://www.chemieliva.com
Contact:+86-23-67770219
Address:99 Longhua Road, Yubei District, 401147, Chongqing, China Email: sales@chemieliva.com Tel:0086-23-67770219 Fax: 0086-23-67770220 Attn: Andy Huang
Ningxia Soochow Agrochemical Limited Company
Contact:(+86)0512 6320 8190
Address:wujiang
SICHUAN TONGSHENG AMINOACID CO.LTD
website:http://www.aminoacid.cc
Contact:86-838-2274206/2850606
Address:Room 1-11-1,No.19 of North TianShan Road,Deyang,Sichuan China
Triumph International Development Limilted
website:http://www.jiashengchem.cn/
Contact:+86-536-7971999
Address:Yinhai Road,Shouguang
Shanghai Bocimed Pharmaceutical Co., Ltd.
website:http://www.bocimed.com
Contact:+86-21-68861632
Address:Building 1, Lane 647, Songtao Road, Zhangjiang High-Tech Park, Shanghai
Doi:10.1246/bcsj.49.730
(1976)Doi:10.1021/acs.orglett.0c02465
(2020)Doi:10.1016/j.chemphyslip.2005.07.007
(2005)Doi:10.1016/S0040-4039(00)86229-2
(1983)Doi:10.1016/j.saa.2007.10.006
(2008)Doi:10.1007/s00044-005-0125-z
(2005)